{
    "clinical_study": {
        "@rank": "159937", 
        "acronym": "PapU-APV", 
        "arm_group": {
            "arm_group_label": "PapU-APV", 
            "arm_group_type": "Other", 
            "description": "No drug and no placebo will be used in this study. For the study participants, only their medical history data and vaginal auto-takings ( APV) and urinary will be collected."
        }, 
        "brief_summary": {
            "textblock": "Auto-takings by APU and vaginal APV during the consultations for FCU in the department of\n      gynecology-obstetrics (Group 1) according to an instructions for use proposed to the\n      inclusive women, with consent; the same proposal, APU and APV, is made for other\n      consultations requiring a screening on the CHRU (Group 2: dermatology, endocrinology,\n      ambulatory surgery, inner medicine, pneumology, oncology). Auto-takings transmitted in the\n      laboratory of the CHRU of Brest for test HPV by quantitative real-time PCR. Results\n      transmitted to the women and to the doctors of consultation. In case of positive test (15\n      %), the patients are directed to a gynecologist. Confrontation with the cytological data\n      when available (Group 1) ."
        }, 
        "brief_title": "Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Research Human Papillomavirus ( HPV) by Vaginal Auto-takings ( APV) and Urinary Test", 
        "condition_browse": {
            "mesh_term": "Uterine Cervical Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All the 25-65-year-old women requiring a screening and seen in consultation of the\n             departments targeted by the CHRU of Brest\n\n        Exclusion Criteria:\n\n          -  Women except age limit, refusal to participate, hysterectomy, pregnancy and\n             post-therapeutic follow-up."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "460", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02137694", 
            "org_study_id": "RB 13.161 PapU-APV"
        }, 
        "intervention": {
            "arm_group_label": "PapU-APV", 
            "description": "vaginal auto-takings  and urinary test", 
            "intervention_name": "vaginal auto-takings  and urinary test", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Papillomavirus", 
            "Vaginal auto-takings", 
            "Urinary test"
        ], 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "contact": {
                "email": "christopher.payan@chu-brest.fr", 
                "last_name": "Christopher Payan, PU-PH", 
                "phone": "2-98-14-51-01", 
                "phone_ext": "+33"
            }, 
            "facility": {
                "address": {
                    "city": "Brest", 
                    "country": "France", 
                    "zip": "29609"
                }, 
                "name": "CHRU de Brest"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Comparison of the Urinary and Vaginal Auto-takings for the Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer.", 
        "overall_official": {
            "affiliation": "CHRU Brest", 
            "last_name": "Christopher PAYAN, PU-PH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Estimate the research for human Papillomavirus ( HPV) in the vaginal auto-takings ( APV) and urinary ( APU) test at women from 25 to 65 years old requiring a screening.", 
            "measure": "Research for human Papillomavirus by vaginal auto-takings and urinary test", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02137694"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Estimate the practicability, the organization of the screening, the follow-up of the women at the CHRU.", 
            "measure": "The global logistic of the study", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "University Hospital, Brest", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Brest", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}